The Hunt for New Antibiotics

Bacterial infections are responsible for one quarter of all deaths, a number that may rise with the alarming increase in multi-drug resistant strains.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Bacterial infections are responsible for one quarter of all deaths, a number that may rise with the alarming increase in multi-drug resistant strains. On page 20 of this feature on antibiotics, Jo Handelsman, of the University of Wisconsin, Madison, writes that applying metagenomic approaches may yield new treatments. "Most of the antibiotics used today are derived from cultured soil bacteria, but these organisms represent only the tip of a microbiological iceberg" she says. But first we take a look at how stopping bacterial evolution could improve the power of new drugs and bolster the ones already at hand.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies